PMC:7696151 / 59361-59706
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1744","span":{"begin":270,"end":277},"obj":"Gene"},{"id":"1749","span":{"begin":165,"end":169},"obj":"Species"},{"id":"1756","span":{"begin":32,"end":35},"obj":"Chemical"},{"id":"1757","span":{"begin":227,"end":230},"obj":"Chemical"},{"id":"1758","span":{"begin":323,"end":330},"obj":"Chemical"},{"id":"1776","span":{"begin":39,"end":70},"obj":"Disease"},{"id":"1777","span":{"begin":156,"end":164},"obj":"Disease"}],"attributes":[{"id":"A1744","pred":"tao:has_database_id","subj":"1744","obj":"Gene:3630"},{"id":"A1749","pred":"tao:has_database_id","subj":"1749","obj":"Tax:10116"},{"id":"A1756","pred":"tao:has_database_id","subj":"1756","obj":"MESH:D006886"},{"id":"A1757","pred":"tao:has_database_id","subj":"1757","obj":"MESH:D006886"},{"id":"A1758","pred":"tao:has_database_id","subj":"1758","obj":"MESH:D005947"},{"id":"A1776","pred":"tao:has_database_id","subj":"1776","obj":"MESH:D044882"},{"id":"A1777","pred":"tao:has_database_id","subj":"1777","obj":"MESH:D003920"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The first proofs of the role of HCQ in glucose and insulin homeostasis date back to 1999, when Emami, Gerstein, Pasutto, and Jamali [105] demonstrated that diabetic rats treated with oral doses of 80, 120, and 160 mg/kg/day of HCQ exhibited a dose-dependent increase in insulin blood levels, with a consequent reduction of glucose concentration."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T382","span":{"begin":0,"end":345},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The first proofs of the role of HCQ in glucose and insulin homeostasis date back to 1999, when Emami, Gerstein, Pasutto, and Jamali [105] demonstrated that diabetic rats treated with oral doses of 80, 120, and 160 mg/kg/day of HCQ exhibited a dose-dependent increase in insulin blood levels, with a consequent reduction of glucose concentration."}